213777-19-6

Basic information

• Product Name: (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-(formylmethyl)-1,4-bis-O-(triethylsilyl)cyclopentane-1,4-diol
• Synonyms: (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-(formylmethyl)-1,4-bis-O-(triethylsilyl)cyclopentane-1,4-diol
• CAS NO: 213777-19-6
• Molecular Weight: 641.126
• Mol File: 213777-19-6.mol

Chemical Properties

• CAS DataBase Reference: (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-(formylmethyl)-1,4-bis-O-(triethylsilyl)cyclopentane-1,4-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-(formylmethyl)-1,4-bis-O-(triethylsilyl)cyclopentane-1,4-diol(213777-19-6)
• EPA Substance Registry System: (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-(formylmethyl)-1,4-bis-O-(triethylsilyl)cyclopentane-1,4-diol(213777-19-6)

Safety Data

• Hazardous Substances Data: 213777-19-6(Hazardous Substances Data)

Upstream product

• 213777-18-5 (1S,2S,3R,4R)-1,4-Bis(triethylsilyloxy)-3-(methoxycarbonylmethyl)-2-tert-butyldiphenylsilyloxymethylcyclopentane 

Downstream Products

• 334670-37-0 (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-[(Z)-5-tetrahydropyranyloxypent-2-enyl]-1,4-bis(triethylsilyl)cyclopentane-1,4-diol 
• 534584-74-2 (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-1,4-bis-O-(triethylsilyl)-3-[(Z)-7-(methoxycarbonyl)hept-2-enyl]cyclopentane-1,4-diol 
• 213777-28-7 (1S,2S,3R,4R)-1,4-di-O-benzoyl-3-(4-methoxycarbonylbutyl)-2-[(3RS,E)-3-hydroxyoct-1-enyl]cyclopentane-1,4-diol 
• 334670-39-2 (1S,2R,3R,4R)-1,4-di-O-benzoyl-2-(tert-butyldiphenylsilyloxymethyl)-3-[(Z)-5-tetrahydropyranyloxypent-2-enyl]cyclopentane-1,4-diol 
• 334670-40-5 (1S,2R,3R,4R)-1,4-di-O-benzoyl-2-(tert-butyldiphenylsilyloxymethyl)-3-[(Z)-5-hydroxypent-2-enyl]cyclopentane-1,4-diol 
• 334670-41-6 (1S,2R,3R,4R)-1,4-di-O-benzoyl-2-(tert-butyldiphenylsilyloxymethyl)-3-[(Z)-4-methoxycarbonylbut-2-enyl]cyclopentane-1,4-diol 
• 334670-36-9 (1S,2S,3R,4R)-1,4-di-O-benzoyl-3-(4-methoxycarbonylbutyl)-2-[(3RS)-octanol]cyclopentane-1,4-diol 
• 334670-35-8 (1S,2S,3R,4R)-1,4-di-O-benzoyl-3-(4-methoxycarbonylbutyl)-2-(3-oxooctanyl)cyclopentane-1,4-diol 
• 334670-46-1 (1S,2S,3R,4R)-1,4-di-O-benzoyl-3-[(Z)-4-methoxycarbonylbut-2-enyl]-2-[(3RS,E)-3-hydroxyoct-1-enyl]cyclopentane-1,4-diol 
• 334670-44-9 (1S,2S,3R,4R)-1,4-di-O-benzoyl-3-[(Z)-4-methoxycarbonylbut-2-enyl]-2-[(E)-3-oxooct-1-enyl]cyclopentane-1,4-diol 
• 334670-38-1 (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-[(Z)-5-tetrahydropyranyloxypent-2-enyl]cyclopentane-1,4-diol 
• 334670-42-7 (1S,2R,3R,4R)-1,4-di-O-benzoyl-3-[(Z)-4-methoxycarbonylbut-2-enyl]-2-(hydroxymethyl)cyclopentane-1,4-diol 
• 334695-89-5 C₂₆H₂₆O₇ 
• 213777-22-1 (1S,2R,3R,4R)-1,4-di-O-benzoyl-2-(tert-butyldiphenylsilyloxymethyl)-3-(5,5-diethoxypentyl)cyclopentane-1,4-diol 

Relevant articles and documents

Total Synthesis of the Eight Diastereomers of the Syn-Anti-Syn Phytoprostanes F1 Types I and II

Syntheses of the eight enantiomerically pure diastereomers of the syn-anti-syn phytoprostanes F1 types I and II are described starting from D- and L-glucose. Key steps include Wittig coupling, Horner Wadsworth Emmons (HWE) reactions, and enantioselective reduction of α,β -unsaturated ketones.

Total synthesis of phytoprostane F1 and its 16 epimer

The first synthesis of the two enantiomers of phytoprostane F1 methyl ester 1 and 2 is described using the syn-anti-syn alcoxy ester 3 as starting material.

Syntheses and preliminary pharmacological evaluation of the two epimers of the 5-F2t-isoprostane

The total synthesis of the 5-F2t-isoprostane 1 and its 5-epimer 2 from diacetone-D-glucose is described. We report preliminary data on the vascular properties of these compounds.

Total syntheses of four metabolites of 15-F2t-isoprostane

Total syntheses are described of the methyl esters of enantiomers of two major urinary metabolites of 15F2t-isoprostane - 2,3-dinor-5,6-dihydro-15F2t-isoprostane 1 and 2,3-dinor15F2t-isoprostane 2 - together with other, related, putative metabolites (15R)/(15S)-2,3-dinor-5,6,13,14-tetrahydro-15F2tisoprostane 3 and 2,3-dinor-5,6,13,14-tetrahydro-15-oxo 15F2t-isoprostane 4. The synthesis, starting from diacetone d-glucose, includes as its main steps a radical cyclization reaction of highly functionalized precursors, followed by Wittig and/or Horner-Wadsworth-Emmons elongation using phosphorus synthons. The compounds synthesized here have been used as reference compounds for studying the metabolism of 15F2t-isoprostane and ent-15F2t-isoprostane.

Total synthesis of 4(RS)-F(4t)-isoprostane methyl ester

The first total synthesis of 4(RS)-F(4t)-isoprostane methyl ester 1 is described using diacetone-D-glucose as starting material. This new isoprostane (neuroprostane) would be very useful in neurological studies as a potent lipid peroxidation in

Total synthesis of ent-15(RS)-2,3-dinor-5,6-dihydro-8-epi-PGF2α.

The first total synthesis of ent-15(RS)-2,3-dinor-5,6-dihydro-8-epi- PGF2α 1 is described using diacetone-D-glucose as starting material. The major urinary metabolite of the isoprostane 8-epi-PGF2α is 2,3-dinor-5,6- dihydro-8-epi-PGF2α, which is a potent lipid peroxidation index to obtain an integrated assessment of oxidative stress in humans.